Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DT.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DT.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DT.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DS.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DS.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DS.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.63NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.63NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DU.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DU.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.53NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.53NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CV.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBKNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBKNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBKNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.14.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.14.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-14980.9Singapore
XBB.1.14.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used